The Cooper Companies, Inc. $COO Shares Acquired by Nisa Investment Advisors LLC

Key Points

• Nisa Investment Advisors increased its Cooper Companies stake by 84.6% in the third quarter, while several other institutional investors, including BlackRock and Bank of America, also established or expanded positions. Institutional investors collectively own 24.39% of the company.
• Analyst sentiment remains mixed, with a consensus “Hold” rating and an average price target of $68.60. Recent actions included downgrades from Zacks Research and Wall Street Zen, alongside a $75 target and “outperform” rating from Mizuho.
• Cooper Companies reported quarterly EPS of $1.15, beating estimates of $1.12, though revenue of $1.07 billion fell short of expectations. The board also authorized a $3 billion share buyback, covering up to 22.7% of outstanding shares, and company directors purchased shares recently.

Nisa Investment Advisors LLC raised its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 84.6% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 192,454 shares of the medical device company's stock after purchasing an additional 88,216 shares during the quarter. Nisa Investment Advisors LLC owned 0.10% of Cooper Companies worth $10,879,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Algert Global LLC acquired a new position in Cooper Companies in the second quarter worth about $7,655,000. Bank of America Corp DE bought a new position in Cooper Companies during the second quarter worth about $144,125,000. BlackRock Inc. acquired a new stake in Cooper Companies during the second quarter valued at approximately $1,077,762,000. National Pension Service boosted its holdings in Cooper Companies by 9,314.0% during the second quarter. National Pension Service now owns 526,149 shares of the medical device company's stock valued at $37,730,000 after purchasing an additional 520,560 shares in the last quarter. Finally, Nykredit A S bought a new stake in shares of Cooper Companies in the 2nd quarter valued at approximately $2,070,000. Institutional investors and hedge funds own 24.39% of the company's stock.

Analyst Upgrades and Downgrades

COO has been the subject of a number of recent research reports. Bank of America reissued a "neutral" rating and issued a $65.00 target price (down from $80.00) on shares of Cooper Companies in a report on Thursday, September 10th. Wall Street Zen lowered Cooper Companies from a "buy" rating to a "hold" rating in a research note on Saturday, September 12th. Barclays raised Cooper Companies to a "hold" rating in a research note on Wednesday, October 7th. Zacks Research cut Cooper Companies from a "hold" rating to a "strong sell" rating in a research report on Friday, September 11th. Finally, Mizuho set a $75.00 price objective on Cooper Companies and gave the stock an "outperform" rating in a research note on Thursday, September 10th. Four investment analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $68.60.

Cooper Companies Stock Performance

NASDAQ COO opened at $61.65 on Friday. The firm has a market cap of $11.72 billion, a price-to-earnings ratio of 21.04, a PEG ratio of 2.40 and a beta of 0.83. The company has a 50 day moving average of $62.09 and a 200-day moving average of $65.80. The company has a current ratio of 1.22, a quick ratio of 0.73 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a 1-year low of $51.01 and a 1-year high of $89.83.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Wednesday, September 9th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.12 by $0.03. The company had revenue of $1.07 billion during the quarter, compared to analysts' expectations of $1.10 billion. Cooper Companies had a net margin of 13.46% and a return on equity of 10.90%. Cooper Companies's quarterly revenue was up .5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.49 earnings per share. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. On average, equities analysts forecast that The Cooper Companies, Inc. will post 4.53 earnings per share for the current fiscal year.

Cooper Companies declared that its board has initiated a share buyback plan on Wednesday, September 9th that allows the company to repurchase $3.00 billion in shares. This repurchase authorization allows the medical device company to repurchase up to 22.7% of its shares through open market purchases. Share repurchase plans are typically an indication that the company's leadership believes its shares are undervalued.

Insider Activity at Cooper Companies

In other Cooper Companies news, Director Lawrence Kurzius acquired 10,000 shares of Cooper Companies stock in a transaction on Wednesday, September 16th. The shares were bought at an average price of $54.93 per share, with a total value of $549,300.00. Following the completion of the purchase, the director owned 31,099 shares in the company, valued at $1,708,268.07. This trade represents a 47.40% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Paul A. Keel acquired 4,701 shares of Cooper Companies stock in a transaction on Friday, September 11th. The stock was acquired at an average cost of $53.18 per share, for a total transaction of $249,999.18. Following the purchase, the director owned 4,701 shares of the company's stock, valued at approximately $249,999.18. This represents a ∞ increase in their position. The SEC filing for this purchase provides additional information. Insiders acquired 34,701 shares of company stock valued at $1,880,039 in the last three months. Corporate insiders own 2.08% of the company's stock.

Cooper Companies Company Profile

CooperCompanies is a global medical device company that develops, manufactures and markets products for vision care and women's health. The company operates through two primary business segments: CooperVision and CooperSurgical.

CooperVision provides contact lenses and related technologies, including products designed for myopia management, astigmatism, presbyopia and other vision-correction needs. Its portfolio includes daily disposable, reusable and specialty contact lenses sold through eye-care professionals and distributors.

CooperSurgical develops products and services for fertility and women's health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.